“Published recently in the prestigious New England Journal of Medicine (NEJM), a study led by Massachusetts-based physician-scientists leads to a disturbing discovery: individuals fully vaccinated and boosted against COVID-19 actually recover markedly more slowly from the illness and surprisingly, even remain contagious for lengthier periods of time as compared to unvaccinated persons.”
From Geert: In my recent article, I explained how C-19 vaccinated populations will soon serve as a reservoir for zoonotic viral disease not only for Monkeypox but also for zoonotic flu. Although I thought avian flu would be the most likely candidate, swine flu should obviously be considered too! Like the situation with Monkeypox, I expect to see more and more cases of zoonotic flu occurring and spreading in the human population. If this is the case, we can conclude that asymptomatic human-to-human transmission is happening! We’ll know very soon…
https://www.cdc.gov/flu/swineflu/spotlights/first-human-infection-2022.htm
“A monkeypox strain has been spotted that is different from the one behind the ongoing outbreak in the West, raising questions about just how long the virus could have been around.”
https://www.newsweek.com/monkeypox-new-strain-two-outbreaks-1730155
And another 26% were fully vaxxed but not boosted. That’s 67% of recent C-19 deaths in San Diego…
https://www.kusi.com/41-of-recent-covid-deaths-among-fully-vaccinated-and-boosted-individuals/
While most of the samples contained vaccine-like virus, some showed “sufficient mutations to be classified as vaccine derived poliovirus.” The UKHSA said this was more concerning as such virus behaves more similarly to “wild polio and may, on rare occasions, lead to cases of paralysis in unvaccinated individuals.”
https://www.cnn.com/2022/08/10/europe/polio-vaccine-children-london-intl/index.html
“I think they are attempting to meet up with the reality that everyone in the public is pretty much done with this pandemic,” said Michael T. Osterholm, an infectious disease expert at the University of Minnesota, referring to the C.D.C.
https://www.nytimes.com/2022/08/11/health/virus-cdc-guidelines.html
“Many of the trials came from the same countries (Egypt, China, India, Iran, Japan, South Korea, and Turkey), and when John Ioannidis, a professor at Stanford University, examined individual patient data from trials submitted from those countries to Anaesthesia during a year he found that many were false: 100% (7/7) in Egypt; 75% (3/ 4) in Iran; 54% (7/13) in India; 46% (22/48) in China; 40% (2/5) in Turkey; 25% (5/20) in South Korea; and 18% (2/11) in Japan. Most of the trials were zombies. Ioannidis concluded that there are hundreds of thousands of zombie trials published from those countries alone.”
Geert Vanden Bossche received his DVM from the University of Ghent, Belgium, and his PhD degree in Virology from the University of Hohenheim, Germany. He held adjunct faculty appointments at universities in Belgium and Germany. After his career in Academia, Geert joined several vaccine companies (GSK Biologicals, Novartis Vaccines, Solvay Biologicals) to serve various roles in vaccine R&D as well as in late vaccine development.
Geert then moved on to join the Bill & Melinda Gates Foundation’s Global Health Discovery team in Seattle (USA) as Senior Program Officer; he then worked with the Global Alliance for Vaccines and Immunization (GAVI) in Geneva as Senior Ebola Program Manager. At GAVI he tracked efforts to develop an Ebola vaccine. He also represented GAVI in fora with other partners, including WHO, to review progress on the fight against Ebola and to build plans for global pandemic preparedness.
Back in 2015, Geert scrutinized and questioned the safety of the Ebola vaccine that was used in ring vaccination trials conducted by WHO in Guinea. His critical scientific analysis and report on the data published by WHO in the Lancet in 2015 was sent to all international health and regulatory authorities involved in the Ebola vaccination program. After working for GAVI, Geert joined the German Center for Infection Research in Cologne as Head of the Vaccine Development Office. He is at present primarily serving as a Biotech / Vaccine consultant while also conducting his own research on Natural Killer cell-based vaccines.
Email: info@voiceforscienceandsolidarity.org
.svg){kind=small}
